Gene Therapy in CNS Disorder - Global and China Top Players Market Share and Ranking 2023

Tables and Figures

Table 1. Gene Therapy in CNS Disorder Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Gene Therapy in CNS Disorder Market Restraints
Table 3. Gene Therapy in CNS Disorder Market Trends
Table 4. Gene Therapy in CNS Disorder Industry Policy
Table 5. Global Gene Therapy in CNS Disorder Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Gene Therapy in CNS Disorder Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Gene Therapy in CNS Disorder Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Gene Therapy in CNS Disorder Mergers & Acquisitions, Expansion Plans
Table 9. Global Gene Therapy in CNS Disorder Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Gene Therapy in CNS Disorder Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 12. China Gene Therapy in CNS Disorder Revenue Market Share by Company, 2018-2023
Table 13. Global Key Players of Gene Therapy in CNS Disorder Upstream (Raw Materials)
Table 14. Global Gene Therapy in CNS Disorder Typical Customers
Table 15. Gene Therapy in CNS Disorder Typical Distributors
Table 16. By Type, Global Gene Therapy in CNS Disorder Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Application, Global Gene Therapy in CNS Disorder Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Gene Therapy in CNS Disorder Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 19. By Region, Global Gene Therapy in CNS Disorder Consumption Value, 2018-2029, US$ Million
Table 20. By Country, Global Gene Therapy in CNS Disorder Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 21. By Country, Global Gene Therapy in CNS Disorder Consumption Value, 2018-2029, US$ Million
Table 22. By Country, Global Gene Therapy in CNS Disorder Consumption Value Market Share, 2018-2029
Table 23. Voyager Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 24. Voyager Therapeutics Company Profile and Main Business
Table 25. Voyager Therapeutics Gene Therapy in CNS Disorder Models, Specifications, and Application
Table 26. Voyager Therapeutics Gene Therapy in CNS Disorder Revenue and Gross Margin, US$ Million, 2018-2023
Table 27. Voyager Therapeutics Recent Developments
Table 28. Spark Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 29. Spark Therapeutics Company Profile and Main Business
Table 30. Spark Therapeutics Gene Therapy in CNS Disorder Models, Specifications, and Application
Table 31. Spark Therapeutics Gene Therapy in CNS Disorder Revenue and Gross Margin, US$ Million, 2018-2023
Table 32. Spark Therapeutics Recent Developments
Table 33. Novartis AG Company Information, Head Office, Market Area and Industry Position
Table 34. Novartis AG Company Profile and Main Business
Table 35. Novartis AG Gene Therapy in CNS Disorder Models, Specifications, and Application
Table 36. Novartis AG Gene Therapy in CNS Disorder Revenue and Gross Margin, US$ Million, 2018-2023
Table 37. Novartis AG Recent Developments
Table 38. Bluebird Bio Inc. Company Information, Head Office, Market Area and Industry Position
Table 39. Bluebird Bio Inc. Company Profile and Main Business
Table 40. Bluebird Bio Inc. Gene Therapy in CNS Disorder Models, Specifications, and Application
Table 41. Bluebird Bio Inc. Gene Therapy in CNS Disorder Revenue and Gross Margin, US$ Million, 2018-2023
Table 42. Bluebird Bio Inc. Recent Developments
Table 43. Biogen Company Information, Head Office, Market Area and Industry Position
Table 44. Biogen Company Profile and Main Business
Table 45. Biogen Gene Therapy in CNS Disorder Models, Specifications, and Application
Table 46. Biogen Gene Therapy in CNS Disorder Revenue and Gross Margin, US$ Million, 2018-2023
Table 47. Biogen Recent Developments
List of Figures
Figure 1. Gene Therapy in CNS Disorder Picture
Figure 2. Global Gene Therapy in CNS Disorder Consumption Value, (US$ million) & (2018-2029)
Figure 3. China Gene Therapy in CNS Disorder Consumption Value, (US$ million) & (2018-2029)
Figure 4. By Consumption Value, China Gene Therapy in CNS Disorder Market Share of Global, 2018-2029
Figure 5. Global Gene Therapy in CNS Disorder Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 6. China Gene Therapy in CNS Disorder Key Participants, Market Share, 2022
Figure 7. Gene Therapy in CNS Disorder Industry Chain
Figure 8. Gene Therapy in CNS Disorder Procurement Model
Figure 9. Gene Therapy in CNS Disorder Sales Model
Figure 10. Gene Therapy in CNS Disorder Sales Channels, Direct Sales, and Distribution
Figure 11. Viral Gene Therapy
Figure 12. Non-viral Gene Therapy
Figure 13. By Type, Global Gene Therapy in CNS Disorder Consumption Value, 2018-2029, US$ Million
Figure 14. By Type, Global Gene Therapy in CNS Disorder Consumption Value Market Share, 2018-2029
Figure 15. Alzheimer's Disease
Figure 16. Huntington's Disease
Figure 17. Parkinson's Disease
Figure 18. Batten Disease
Figure 19. By Application, Global Gene Therapy in CNS Disorder Consumption Value, 2018-2029, US$ Million
Figure 20. By Application, Global Gene Therapy in CNS Disorder Consumption Value Market Share, 2018-2029
Figure 21. By Region, Global Gene Therapy in CNS Disorder Consumption Value Market Share, 2018-2029
Figure 22. North America Gene Therapy in CNS Disorder Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 23. By Country, North America Gene Therapy in CNS Disorder Consumption Value Market Share, 2022
Figure 24. Europe Gene Therapy in CNS Disorder Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 25. By Country, Europe Gene Therapy in CNS Disorder Consumption Value Market Share, 2022
Figure 26. Asia Pacific Gene Therapy in CNS Disorder Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 27. By Country/Region, Asia Pacific Gene Therapy in CNS Disorder Consumption Value Market Share, 2022
Figure 28. South America Gene Therapy in CNS Disorder Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 29. By Country, South America Gene Therapy in CNS Disorder Consumption Value Market Share, 2022
Figure 30. Middle East & Africa Gene Therapy in CNS Disorder Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 31. U.S. Gene Therapy in CNS Disorder Consumption Value, 2018-2029, US$ Million
Figure 32. By Type, U.S. Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
Figure 33. By Application, U.S. Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
Figure 34. Europe Gene Therapy in CNS Disorder Consumption Value, 2018-2029, US$ Million
Figure 35. By Type, Europe Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
Figure 36. By Application, Europe Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
Figure 37. China Gene Therapy in CNS Disorder Consumption Value, 2018-2029, US$ Million
Figure 38. By Type, China Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
Figure 39. By Application, China Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
Figure 40. Japan Gene Therapy in CNS Disorder Consumption Value, 2018-2029, US$ Million
Figure 41. By Type, Japan Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
Figure 42. By Application, Japan Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
Figure 43. South Korea Gene Therapy in CNS Disorder Consumption Value, 2018-2029, US$ Million
Figure 44. By Type, South Korea Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
Figure 45. By Application, South Korea Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
Figure 46. Southeast Asia Gene Therapy in CNS Disorder Consumption Value, 2018-2029, US$ Million
Figure 47. By Type, Southeast Asia Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
Figure 48. By Application, Southeast Asia Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
Figure 49. India Gene Therapy in CNS Disorder Consumption Value, 2018-2029, US$ Million
Figure 50. By Type, India Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
Figure 51. By Application, India Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
Figure 52. Middle East & Africa Gene Therapy in CNS Disorder Consumption Value, 2018-2029, US$ Million
Figure 53. By Type, Middle East & Africa Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
Figure 54. By Application, Middle East & Africa Gene Therapy in CNS Disorder Consumption Value Market Share, 2022 VS 2029
Figure 55. Research Methodology
Figure 56. Breakdown of Primary Interviews
Figure 57. Bottom-up and Top-down Approaches
Figure 58. Top-down Approaches

Reason to Buy

• Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Pharma & Healthcare Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets